Philips (PHG) announced it has received 510 clearance from the FDA for its Rembra platform of scanning systems, including Rembra CT, Rembra RT and Areta RT. The newly cleared systems are designed to help healthcare providers respond to growing demand for imaging and radiation therapy planning by helping to improve speed, efficiency, and access to high-quality imaging. As imaging volumes and clinical complexity continue to rise, healthcare providers need solutions that can help them work more efficiently while maintaining confidence in clinical decisions.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PHG:
- Philips receives FDA 510(k) clearance for Verida system
- Philips price target lowered to EUR 25 from EUR 29 at Deutsche Bank
- Philips Refreshes Supervisory Board and Seeks CEO Re‑Appointment Ahead of May 2026 AGM
- Philips Sets May 8, 2026 AGM to Vote on Board, CEO Reappointment and Dividend
- Philips announces FDA clearance for EchoNavigator R5.0 with DeviceGuide